← All trials
NCT06158828
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2024
- Primary completion
- Jul 15, 2028
- Completion date
- Mar 31, 2030
- First posted
- Dec 6, 2023
- Last posted
- Dec 6, 2023
- Enrollment
- 48
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Washington University in St. LouisLead sponsor
- Rising Tide FoundationCollaborator
- The Leukemia and Lymphoma SocietyCollaborator
- Washington University in St. LouisOverall official - principal investigator
- Washington University in St. LouisOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.